The CEO of Northfield-based Medline cheered the company’s successful initial public offering late last year while discussing how tariffs have taken a bite out of its profits, in an interview with the ...

NORTHFIELD, Ill., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that it plans to report fourth quarter and full year 2025 financial results on Wednesday, ...

“Medline’s IPO was the largest private equity-backed IPO of all time, the largest healthcare IPO ever and the largest public offering of 2025, having traded up strongly on debut,” Robert Schmidt, ...

Medline has struck a series of new and expanded partnerships with health systems in recent months, reinforcing its position as a major supply chain player in both medical-surgical and laboratory ...

Medline CEO Jim Boyle (R) celebrates after ringing the opening bell at Nasdaq Marketsite headquarters on Dec. 17, 2025. Photo by Michael M. Santiago/Getty Images A blockbuster IPO from an ...

Medline Inc. completed a record-setting $6.26B IPO, allocating proceeds primarily to reduce leveraged buyout debt from 2021. MDLN operates globally with $20.6B YTD revenue, stable 10% growth, and ...

Medline completed a highly successful IPO, now trading at a $83 billion valuation, being granted a demanding 39x earnings multiple. Medline generates $25.5 billion in annual revenue, up 10% ...

Shares of Medline, a medical-supplies manufacturer and distributor, rose 41% in their trading debut Wednesday after the company raised $6.26 billion in the largest U.S. initial public offering since ...

Medline Inc. (NASDAQ: MDLN) shares are trending on Thursday. Check out the current price of MDLN stock here. Shares of the healthcare company surged 41.38% in regular trading hours on Wednesday, ...

When the Mills family sold Medline Inc. to private equity in one of the largest leveraged buyouts ever, the $32 billion deal seemed the apotheosis of a Covid economy defined by low interest rates and ...

Monday - Friday, 6:00 - 7:00 PM ET CNBC's Jim Cramer reviewed Medline, a medical supplies giant that made its market debut Wednesday. He said he'd wait for a pullback to buy the stock after shares ...

Medline shares close 41% above offer price in debut Tariffs pose a challenge for Medline SpaceX, others eye 2026 listing Dec 17 (Reuters) - Medical supply giant Medline's shares rose 41% above their ...